Domeject AB is a Swedish MedTech startup incorporated in April 2022, based in Rejmyre, Finspång, Sweden (Org.nr: 559376-0407). The company has developed the ReDosa™ hybrid syringe system, which replaces up to 8 single-use syringes with one reusable injector and a disposable capsule, reducing plastic waste by 85%. The company is pre-revenue and pre-CE certification, currently participating in Sweden’s Innovation Fast Track programme.